Casimiro PT / Shutterstock.com
Médecins Sans Frontières (MSF) has warned that the European Commission’s commitment to the supplementary protection certificate (SPC) system risks undermining its promise to improve drug accessibility.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
MSF, European Commission, SPCs, drug accessibility, generics, Amaryllis Verhoeven